Biotech company developing therapies targeting gut-brain axis interactions to treat metabolic and neurological diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Kallyope is a biotechnology company focused on harnessing the gut-brain axis to develop innovative therapies for various health conditions. Kallyope aims to unlock the complex interactions between metabolic, neurological, and gastrointestinal systems to create effective treatments for diseases such as obesity, diabetes, and neurological disorders.
Kallyope Funding
Sign up to gain insights into Kallyope funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series E | Oct 01, 2026 | 94M | ||
| Series D | Feb 15, 2022 | 236M | ||
| Series C | Mar 18, 2020 | 112M | ||
| Series B | Dec 05, 2018 | 21M | ||
| Series B | Feb 22, 2018 | 66M | ||
| Series A | Oct 27, 2016 | 16M | ||
| Series A | Sep 30, 2015 | 12M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Kallyope Management Team
Investors
Alexandria Venture Investments
Bill Gates
Casdin Capital
Column Group
DNS Capital, LLC
Euclidean Capital
Greenspring Associates
Hartford HealthCare Endowment
Illumina, Inc.
Individuals
Lux Capital
Mubadala Investment Company
Parkwood LLC
Polaris Partners
StepStone Group LLC
Tao Capital Partners
TCG X
Two Sigma Ventures
Viking Global Investors
Kallyope Valuations & Financials
View real-time NPM data on Kallyope stock including daily Kallyope stock price estimates, valuation history, and historical share price information. Access Kallyope financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Kallyope pricing across six independent market signals. Looking for private company due diligence data sources on Kallyope? Get in touch to learn more.
Similar Companies
like Kallyope
BillionToOne
Healthcare & Life Sciences
Developed a DNA molecular counting technology for detecting gene disorders through a blood test.
Workit Health
Healthcare & Life Sciences
Provider of clinically proven telemedicine treatment for substance use disorder.
Judi Health
Healthcare & Life Sciences
Healthcare technology company that manages pharmacy benefits.
TripleBar
Healthcare & Life Sciences
Creates products that nourish, heal, and sustain both people and the planet.
Hone Health
Healthcare & Life Sciences
Online clinic specializing in preventative and proactive longevity care.
Clear Labs
Healthcare & Life Sciences
Pioneers in food analytics, enabling brands to differentiate on quality and ensure value.
HiberCell
Healthcare & Life Sciences
Develops therapies targeting adaptive stress mechanisms to overcome cancer treatment resistance.
Tend
Healthcare & Life Sciences
Modern dental care provider delivering personalized, comfortable experiences through patient-centered services and transparent practices.
VillageMD
Healthcare & Life Sciences
Partners with primary care physicians to deliver value-based healthcare through integrated technology and care management solutions.
FAQ
We have answers
Kallyope stock does not trade on public stock exchanges. Kallyope stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Kallyope stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Kallyope Stock does not trade on public stock exchanges. In order to sell Kallyope shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Kallyope does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Kallyope share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Kallyope stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Kallyope stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Kallyope stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Kallyope is a private company and has not had an IPO. There is currently no Kallyope IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Kallyope IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
